WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 2 fonti

FDA Greenlights Generic Rifapentine for Tuberculosis

Generic approved as part of combination regimens for active and latent pulmonary TB

Raccontata dahealio.commedpagetoday.com

Confronto fonti

2 prospettive sulla stessa storia
AI · summaries
medpagetoday.comStai leggendo14 g fa

FDA Greenlights Generic Rifapentine for Tuberculosis

Generic approved as part of combination regimens for active and latent pulmonary TB

originale
healio.com14 g fa

FDA approves Priftin generic for two types of tuberculosis

The FDA announced approval of generic Priftin tablets to treat two types of tuberculosis caused by Mycobacterium tuberculosis, marking the first generic of this drug, according to an agency notice.The FDA outlined that…

Leggi questa versione → originale

Timeline cronologica

  1. martedì 23 giugno 2026·healio.com

    FDA approves Priftin generic for two types of tuberculosis

    The FDA announced approval of generic Priftin tablets to treat two types of tuberculosis caused by Mycobacterium tuberculosis, marking the first generic of this drug, according to…

  2. martedì 23 giugno 2026·medpagetoday.com

    FDA Greenlights Generic Rifapentine for Tuberculosis

    Generic approved as part of combination regimens for active and latent pulmonary TB